RecruitingNCT05510934
Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.
Sponsor
Nova Scotia Health Authority
Enrollment
60 participants
Start Date
Sep 30, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to assess the feasibility of a shared-care model for low-risk differentiated thyroid cancer (DTC) patients, primary care practitioners (PCPs) and the tertiary care center utilizing a digital health-based thyroid cancer assessment reminder system (TCARS) in Medable with an expedited referral to specialists for rapid assessment in case of a concern of recurrence.
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- Adult (\>18 years old) consenting patients being followed at the Halifax Interdisciplinary Thyroid Oncology Clinic (ITOC) meeting the following criteria:
- AJCC stage 1 DTC with no radiological or biochemical evidence of thyroid cancer with undetectable high sensitivity serum thyroglobulin (hsTG \<0.06 mcg/L\*);
- Anti-thyroglobulin antibody (anti-TG AB \<20 IU/ml\*);
- Thyroid ultrasound scan \[USS\] negative for regional recurrence at least 24 months after most recent treatment;
- AJCC stage 2 DTC with no radiological or biochemical evidence of cancer (undetectable hsTG and anti-TG AB and negative thyroid USS) at least 48 months after most recent treatment
- Patient is comfortable with using the mobile or Medable application and has access to internet.
Exclusion Criteria1
- Patient does not have a consented PCP.
Interventions
BEHAVIORALShared-care model
A Shared care follow-up strategy involving patients, PCPs and specialists that uses an automated reminder system (TCARS).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05510934